Evidence map›Paper›PMID 25479313›Full record

ReviewCurrent opinion in allergy and clinical immunology2015

Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation.

Rohit Divekar, Hirohito Kita

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Histamine-releasing factor enhances food allergy.The Journal of clinical investigation · 2017
    Trial
  4. Review
  5. Article
  6. Review
  7. AAntioxidants (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Type 2 immunity in allergic diseases.Cellular & molecular immunology · 2025
    Review
  19. Review
  20. The role of innate immune system in respiratory viral infection related asthma.Frontiers in cellular and infection microbiology · 2025
    Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rohit DivekarDivision of Allergic Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Hirohito Kita
Mayo Clinic · US

Funding

The Pathogenesis of Chronic RhinosinusitisR01AI049235 · NIAID · MAYO CLINIC ROCHESTER · PI KITA, HIROHITO · 2001 to 2011
$4.5M
The Pathogenesis of Chronic RhinosinusitisR56AI049235 · NIAID · MAYO CLINIC ROCHESTER · PI KITA, HIROHITO · 2012 to 2012
$278k
NIAID NIH HHS R01 AI049235NIAID NIH HHS R56 AI049235NIAID NIH HHS R56 AI49235
6 · The paper itself

Abstract

purpose of reviewAllergic diseases are thought to be driven by aberrant immune responses. Epithelium responds to various environmental factors by releasing key cytokines, such as thymic stromal lymphopoietin (TSLP), IL-33, and IL-25. Although there are important differences among these cytokines, there are also similarities which confound a clear understanding of the exact roles of these cytokines. The purpose of this review is to analyze the advances in biology and functions of these cytokines over recent years, elucidate their differences and similarities, and provide new conceptual understanding as to their roles in allergic diseases. RECENT

findingsThere are distinct differences in the timing, onset, and kinetics of the responses and perhaps in the potency of action of TSLP, IL-33, and IL-25. Newer roles of these cytokines have been described, including airway remodeling and fibrosis-related functions (TSLP, IL-33, and IL-25), fetal-maternal interface (IL-33 and TSLP), T-cell biology (TSLP), group 2 innate lymphoid cell biology (TSLP, IL-33, and IL-25), and mast cell-neutrophil axis (IL-33). Novel roles of these cytokines in the pathogenesis of atopic dermatitis and asthma have also been described. SUMMARY: TSLP, IL-25, and IL-33 are increasingly recognized to play important roles in the pathophysiology of allergic diseases. More clear recognition of the differences and similarities of the immunological pathways mediated by these cytokines would help optimize the treatment for allergic diseases.

Indexed as

AnimalsCytokinesHumansHypersensitivityInflammationInterleukin-17Interleukin-33InterleukinsRespiratory MucosaThymic Stromal LymphopoietinCytokinesIL25 protein, humanIL33 protein, humanInterleukin-17Interleukin-33InterleukinsThymic Stromal Lymphopoietin

Identifiers

PMID25479313
PMCPMC4346181
OpenAlexW2461747480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.